Holen Sie sich die Stockscreener-App
1.94
3.48%
-0.07
Handel nachbörslich:
1.93
-0.01
-0.52%
Schlusskurs vom Vortag:
$2.01
Offen:
$2.02
24-Stunden-Volumen:
364.97K
Relative Volume:
0.45
Marktkapitalisierung:
$125.68M
Einnahmen:
$212.69M
Nettoeinkommen (Verlust:
$-59.00M
KGV:
-2.0778
EPS:
-0.9337
Netto-Cashflow:
$-29.49M
1W Leistung:
+6.01%
1M Leistung:
+7.18%
6M Leistung:
-42.26%
1J Leistung:
-71.55%
1-Tages-Spanne:
$1.805
$2.02
1-Wochen-Bereich:
$1.78
$2.23
52-Wochen-Spanne:
$1.17
$7.78
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.94 | 130.22M | 212.69M | -59.00M | -29.49M | -0.9337 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-12-31 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-08 | Herabstufung | Truist | Buy → Hold |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
| 2022-05-12 | Eingeleitet | BTIG Research | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Treace Medical Concepts (TMCI) Price Target Decreased by 35.65% to 5.58 - MSN
Treace Medical Concepts Q1 Earnings Call Highlights - MarketBeat
Treace Medical Concepts (TMCI) Q4 Loss Narrowing To US$0.15 EPS Tests Bearish Narratives - Sahm
Treace Medical Concepts: Q1 Earnings Snapshot - theheraldreview.com
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Hikes on Q1 Numbers - Baystreet.ca
Treace Medical Concepts, Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Treace Medical Concepts beats Q1 2026 forecasts By Investing.com - Investing.com Australia
Earnings call transcript: Treace Medical Concepts beats Q1 2026 forecasts - Investing.com
Treace Medical Concepts Backs 2026 Rev $202M-$212M >TMCI - Moomoo
Treace Medical Concepts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Treace Medical Concepts Inc (NASDAQ:TMCI) Jumps 9% Pre-Market After Q1 Earnings Beat Despite Revenue Decline - ChartMill
Treace Medical Concepts Reports First Quarter 2026 Financial Results - The Manila Times
Treace Medical Concepts reports Q1 2026 revenue $47.2M, net loss $18.0M, reaffirming 2026 guidance - TradingView
[10-Q] TREACE MEDICAL CONCEPTS, INC. Quarterly Earnings Report - Stock Titan
Bunion surgery device maker posts 10% sales drop, keeps 2026 target - Stock Titan
Treace Medical (NASDAQ: TMCI) Q1 2026 sales fall 10% as losses widen - Stock Titan
Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring A Potential 121% Upside - DirectorsTalk Interviews
Treace Medical Concepts Inc (TMCI) Q1 2026 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
How The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst Expectations - Yahoo Finance
Treace Medical Concepts (TMCI) to Release Earnings on Friday - MarketBeat
Treace Medical Concepts (TMCI) price target increased by 12.28% to 4.08 - MSN
Weber Capital Management LLC ADV Invests $1.45 Million in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded to Sell at Wall Street Zen - MarketBeat
Zimmer Biomet sued for violating Treace Medical patents related to bunion treatment - MSN
Treace to Report First Quarter 2026 Financial Results on May 8, 2026 - The Manila Times
Treace Medical Concepts, Inc. to Release First Quarter 2026 Financial Results and Host Conference Call - Quiver Quantitative
Before markets open May 8, Treace will post results and hold an 8 a.m. ET call - Stock Titan
TMCI (Treace Medical Concepts Inc.) notches narrow Q4 2025 EPS beat, shares rise 3.74 percent on positive investor sentiment.Stock Community Signals - UBND thành phố Hải Phòng
Treace Medical Concepts Inc. (TMCI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Treace Medical Concepts (TMCI) CFO reports 11,547-share tax withholding - Stock Titan
Treace Medical Concepts, Inc. (TMCI) LawsuitInvestors Urged to Contact Levi & Korsinsky Before June 10, 2025 - The National Law Review
Wall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong Sell - MarketBeat
How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans - Yahoo Finance
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a 127% Potential Upside Amidst Challenges - DirectorsTalk Interviews
TMCI Faces Ownership Changes: Market Reactions Unclear - StocksToTrade
US Stocks Mixed; Dow Falls Over 100 Points - Sahm
Wall Street Zen Upgrades Treace Medical Concepts (NASDAQ:TMCI) to Sell - MarketBeat
Chart Watch: Will Treace Medical Concepts Inc outperform tech stocksMarket Performance Report & Verified Momentum Stock Ideas - baoquankhu1.vn
Treace Medical Concepts Announces Leadership Transition and Outlook - The Globe and Mail
Stifel maintains Hold on Treace Medical stock, $3 target unchanged By Investing.com - Investing.com India
Stifel maintains Hold on Treace Medical stock, $3 target unchanged - Investing.com
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):